chrX-65488859-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001010888.4(ZC3H12B):c.58G>A(p.Glu20Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000497 in 1,206,707 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001010888.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZC3H12B | NM_001010888.4 | c.58G>A | p.Glu20Lys | missense_variant | 6/10 | ENST00000338957.5 | NP_001010888.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZC3H12B | ENST00000338957.5 | c.58G>A | p.Glu20Lys | missense_variant | 6/10 | 1 | NM_001010888.4 | ENSP00000340839 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000894 AC: 1AN: 111840Hom.: 0 Cov.: 22 AF XY: 0.0000294 AC XY: 1AN XY: 33994
GnomAD3 exomes AF: 0.0000117 AC: 2AN: 171427Hom.: 0 AF XY: 0.0000171 AC XY: 1AN XY: 58335
GnomAD4 exome AF: 0.00000457 AC: 5AN: 1094867Hom.: 0 Cov.: 31 AF XY: 0.00000832 AC XY: 3AN XY: 360623
GnomAD4 genome AF: 0.00000894 AC: 1AN: 111840Hom.: 0 Cov.: 22 AF XY: 0.0000294 AC XY: 1AN XY: 33994
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.58G>A (p.E20K) alteration is located in exon 1 (coding exon 1) of the ZC3H12B gene. This alteration results from a G to A substitution at nucleotide position 58, causing the glutamic acid (E) at amino acid position 20 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at